)
Treace Medical Concepts (TMCI) investor relations material
Treace Medical Concepts 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic direction and market positioning
Expanded from a single Lapiplasty technology to a comprehensive 3D bunion solutions portfolio, targeting all four classes of bunion deformities with advanced systems.
Now serves over 3,300 surgeon customers, achieving a 21% CAGR in surgeon user growth over five years and nearly 8% market penetration in 2025.
Focused on increasing wallet share by addressing the remaining 75% of customers' bunion-related cases with new technologies.
Maintains a direct sales force for about 70-75% of revenue, with targeted expansion in key territories and ongoing recruitment of experienced reps.
Strategy includes adding complementary technologies and expanding into adjacent procedures to further penetrate the $5B+ U.S. bunion market.
Product innovation and clinical outcomes
Launched Nanoplasty and Percuplasty 3D MIS systems, Speed MTP, and Micro-Lapiplasty, targeting high-volume osteotomy and MTP fusion segments.
Lapiplasty Lightning, a next-generation platform, aims for faster, more accurate procedures and broader surgeon appeal, with full commercialization expected by end of 2026.
Peer-reviewed four-year interim results from the ALIGN3D study showed 81% pain reduction and low recurrence rates at 48 months, reinforcing Lapiplasty as the gold standard.
IntelliGuide PSI platform offers personalized, preoperative planning and patient-specific cut guides for complex cases.
New biologics and fixation products, such as Percuplasty SuperBite, are being added to support core procedures.
Market trends, opportunity, and adoption
Estimated 67 million US adults affected by bunions, with 4.4 million seeking treatment annually and 1.1 million surgical candidates.
Bunion market remains under-penetrated, with only half of surgical candidates opting for surgery due to concerns over pain and recovery.
Surgeons are rapidly adopting new MIS technologies, with hundreds of first-time users enabled in 2025 and strong positive feedback.
MIS procedures currently represent 10-15% of osteotomies but are expected to grow as learning curves decrease and outcomes improve.
56% of bunion patients would be more interested in surgery if offered a minimally invasive option.
- TimeTickerHeadlineOpen
- 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026. - 6 FebARI
Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy. - 6 FebSMCI
Q2 revenue jumped 123% to $12.7B, with FY26 guidance raised to at least $40B. - 6 FebRJF
Record revenues and assets, higher dividend, and acquisitions despite lower net income. - 6 FebFFIE
Raising capital for global EV and AI expansion, with regulatory and dilution risks highlighted.
Next Treace Medical Concepts earnings date
Next Treace Medical Concepts earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)